Legacy Capital Group California’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-2,234
Closed -$202K – 332
2026
Q1
$202K Buy
+2,234
New +$205K 0.08% 273
2025
Q4
– Sell
-2,191
Closed -$216K – 365
2025
Q3
$216K Buy
+2,191
New +$217K 0.06% 320
2025
Q2
– Sell
-2,154
Closed -$244K – 357
2025
Q1
$244K Sell
2,154
-15
-0.7% -$1.6K 0.08% 271
2024
Q4
$229K Sell
2,169
-2
-0.1% -$215 0.07% 291
2024
Q3
$234K Sell
2,171
-95
-4% -$10.4K 0.08% 285
2024
Q2
$246K Buy
2,266
+27
+1% +$3.18K 0.09% 266
2024
Q1
$296K Sell
2,239
-26
-1% -$3.25K 0.11% 227
2023
Q4
$276K Sell
2,265
-470
-17% -$52.4K 0.11% 232
2023
Q3
$307K Buy
2,735
+494
+22% +$62.7K 0.13% 209
2023
Q2
$326K Buy
2,241
+77
+4% +$10.5K 0.13% 201
2023
Q1
$280K Buy
+2,164
New +$272K 0.14% 196

Other funds holding ZBH

Legacy Capital Group California's ZBH Position: Q2 2026 in Review

Legacy Capital Group California sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 2,234 shares — an estimated $202K sold.

Legacy Capital Group California first reported a position in ZBH in Q1 2023 and held it in 11 quarters. The position peaked at $326K in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Legacy Capital Group California reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
  • Legacy Capital Group California sold 2,234 Zimmer Biomet shares in Q2 2026, an estimated $202K.
  • Legacy Capital Group California first reported a position in Zimmer Biomet in Q1 2023 and held it in 11 quarters.
  • Legacy Capital Group California's Zimmer Biomet position peaked at $326K in Q2 2023.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Legacy Capital Group California's 13F filing for Q2 2026, filed 29 Jul 2026.